相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concurrent gastrointestinal perforation and pulmonary embolism due to bevacizumab in an adult undergoing treatment for stage IV colon cancer
Sana Qureshi et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2017)
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101)
Koji Ando et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-YBevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer
Virginia M. Rosen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options
Bruce J. Aungst
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy
Tsunekazu Mizushima et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Carmine Pinto et al.
CLINICAL COLORECTAL CANCER (2017)
Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer
Yutaka Kimura et al.
MOLECULAR MEDICINE REPORTS (2016)
Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer
Hriday Bera et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model
Toshiki Iwai et al.
ONCOLOGY REPORTS (2016)
Thymidine Phosphorylase in Cancer; Enemy or Friend?
Yasir Y. Elamin et al.
CANCER MICROENVIRONMENT (2016)
Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions
Candice Chapouly et al.
BRAIN (2015)
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients
Maurice C. van Staveren et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Thymidine Phosphorylase Participates in Platelet Signaling and Promotes Thrombosis
Wei Li et al.
CIRCULATION RESEARCH (2014)
Recent studies of 5-fluorouracil resistance in pancreatic cancer
Wei-Bin Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy
Ming-Yii Huang et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors
I. V. Bijnsdorp et al.
BRITISH JOURNAL OF CANCER (2011)
Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells
Louisa von Baumgarten et al.
CLINICAL CANCER RESEARCH (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
The Dual Role of Thymidine Phosphorylase in Cancer Development and Chemotherapy
Annelies Bronckaers et al.
MEDICINAL RESEARCH REVIEWS (2009)
Thymidine phosphorylase inhibits the expression of proapoptotic protein BNIP3
Ryuji Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Targeting platelet-derived endothelial cell growth factor thymidine phosphorylase for cancer therapy
Sandra Liekens et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Revacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy
Paxton V. Dickson et al.
CLINICAL CANCER RESEARCH (2007)
Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer
C Jakob et al.
JOURNAL OF PATHOLOGY (2004)
Thymidine phosphorylase inhibits apoptosis induced by cisplatin
R Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer
KJ O'Byrne et al.
BRITISH JOURNAL OF CANCER (2000)
Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer
N Seki et al.
EUROPEAN JOURNAL OF CANCER (2000)
分享论文
